- Email: [email protected]
Eleventh Annual Clinical Nephrology Meetings Abstracts April 17-21, 2002
Eleventh Annual Clinical Nephrology Meetings Abstracts April 17-21, 2002 Acute Renal Failure/ICU Medicine 51
Acute Renal Failure Due to Ephedra-Containing Dietary Supplements Brenda May-DePaola, Ronnie Garcia, and Ronald Miller Internal Medicine Department, Naval Medical Center, Portsmouth, VA
14
A Randomized Controlled Trial of N-Acetylcysteine to Prevent Contrast Nephropathy Following Coronary Angiography Christopher Caputo, John H. Dokko, John H. Durham, Mohsen Pahlavan, Jan Keltz, Paula Dutka, Kevin Marzo, Tommy Zaharakis and Steven Fishbane Divisions of Nephrology and Hypertension and Cardiology, Winthrop University Hospital, Mineola, NY
21
A Retrospective Analysis of Oral Acetylcysteine Intervention to Prevent Radiographic Contrast-Induced Nephropathy in Patients Undergoing Coronary Angiography With Elevated Serum Creatinine Craig W. Erickson, Janet E. Erickson, Greg Wilsker, and Larissa Brunner Lehigh Valley Hospital, Department of Internal Medicine & Family Practice, Allentown, PA
6
A Retrospective Study of the Incidence of Acute Renal Failure (ARF) Associated With Milrinone Therapy Kamal Amin and Bahar Bastani Division of Nephrology, St Louis University School of Medicine, St Louis, MO
68
Continuous Renal Replacement Therapy in Critically Ill Patients: Patient Survival, Renal Function Recovery, and Associated Complications Sai Subhodhini Reddy, Arlene Sherman, and Rebeca Monk University of Rochester Medical Center, Rochester, NY
42
Extended Daily Dialysis (EDD) Controls Azotemia in Intensive Care Unit (ICU) Patients With Acute Renal Failure (ARF) Victoria A. Kumar, Robert Tseng, and Thomas A. Depner
23
Is Continuous Infusion Better Than Bolus Furosemide in Promoting Urine Flow Rate (UFR) in Acute Renal Failure? Ali Ghorbani, Asad Majid, Heena Contractor, Abbas Rabiei, Karthik Ranganna, Maria Smalley, Jean Lee, and Ziauddin Ahmed Medical College of Pennsylvania Hospital, Philadelphia, PA
79
Urea Volume of Distribution (Vurea) and Total Body Water (TBW) in Patients With Acute Renal Failure (ARF) M. Tugrul Sezer, Sree Hariachar, Nancy Gritter, Paul Flakoll, Deanne Levenhagen, Emil Paganini, Raymond M. Hakim, Jonathan Himmelfarb, and T. Alp Ikizler Vanderbilt University Medical Center, Nashville, TN; Cleveland Clinic Foundation, Cleveland, OH; and Maine Medical Center, Portland, ME
American Journal of Kidney Diseases, Vol 39, No 4 (April), 2002: pp A1-A35
A1
A2
ELEVENTH ANNUAL CLINICAL NEPHROLOGY MEETING ABSTRACTS
Diabetes 72
Albuminuria in the Type 2 Diabetic Baboon Hernan Rincon-Choles, Jeffrey L. Barnes, Xing L. Wang, Robert E. Shade, Joseph R. Haywood, Kenneth D. Carey, Anthony G. Comuzzie, and Hanna E. Abboud ALM VA Hospital, University of Texas Health Sciences Center, and SW Foundation for Biomedical Research, San Antonio, TX
61
Prevalence of Anemia in Diabetic Patients With Chronic Kidney Disease and Treatment With Epoetin Alfa Once Weekly Robert Provenzano, Daniel Lorber, and William McClellan Department of Nephrology, St John Hospital and Medical Center, Detroit, MI; Division of Endocrinology, New York Hospital Medical Center of Queens, Flushing, NY; and Department of Epidemiology, Emory University, Atlanta, GA
31
Transforming Growth Factor- (TGF-) System and Genetic Predisposition to Diabetic Nephropathy (DN) Chunmei Huang, Youngki Kim, M. Luiza A. Caramori, Alfred J. Fish, Stephen S. Rich, Michael E. Miller, Greg Russell, and Michael Mauer University of Minnesota, Minneapolis, MN; and Wake Forest School of Medicine, Winston-Salem, NC
Electrolyte and Acid Base Abnormalities 12
Acute Effect of CO2 on the Tyrosine Phosphorylation of Proteins in the Rabbit Renal Proximal Tubule Patrice Bouyer, Yuehan Zhou, Jose D. Rojas, and Walter F. Boron Yale University School of Medicine, Department of Cellular and Molecular Physiology, New Haven, CT
57
Albumin Accounts Entirely for the Anion Gap and, Via Na Speciation, Affects Calculated Osmolality L. Ovadje, M. McClendon, C. McFarren, V. Namrungroad, N. Purohit, R. Lopez, M. Blakenship, and J.A. Durr University of South Florida, College of Medicine, Tampa, FL
11 Characterization of V2 Vasopressin Receptor Distribution and Internalization in Polarized LLC-PK1 Cells Richard Bouley, Herbert Y. Lin, and Dennis A. Ausiello Massachusetts General Hospital, Renal Unit, Boston, MA 63
Cidofovir Induced Fanconi Syndrome and Nephrogenic Diabetes Insipidus Nash Purohit, Jacques Durr, and Ramon Lopez University of South Florida College of Medicine, Division of Nephrology, Tampa, FL; and Bay Pines VAMC, St Petersburg, FL
83
Constitutive Aquaporin 2 Recycling Occurs Via a Dynamin-Dependent and Clathrin-Mediated Endocytotic Pathway: S256 Phosphorylation Is Not a Requirement for the Constitutive Recycling Tian-Xiao Sun, Alfred Van Hoek, Yan Huang, Karen Blackburn, Margaret McLaughlin, and Dennis Brown Program in Membrane Biology, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA
73
Na Transport by Autosomal Recessive Polycystic Kidney Disease (ARPKD) Cystic Epithelia Rajeev Rohatgi, Patricia Wilson, and Lisa M. Satlin Divisions of Renal Medicine and Pediatric Nephrology, Mount Sinai School of Medicine, New York, NY
ELEVENTH ANNUAL CLINICAL NEPHROLOGY MEETING ABSTRACTS
7
A3
New Fluid Prescriptions for Dysnatremia Noha Barsoum and Barton Levine VAGLAHS and UCLA School of Medicine, Los Angeles, CA
Glomerular Diseases 96
Acute Renal Failure in Focal Segmental Glomerulosclerosis Resolved With Diuresis and Steroids Maria Criselda B. Zaldivar, Irfan S. Chughtai, Harold T. Yamase, and Andre A. Kaplan Nephrology Division, Department of Medicine and Department of Pathology, University of Connecticut Health Center, Farmington, CT
55
Successful Treatment of Unilateral Renal Vein Thrombosis Associated With Lupus Nephritis Using Systemic Thrombolysis Chike M. Nzerue Renal Section, Department of Medicine, Morehouse School of Medicine, Atlanta, GA
26
Genetic Polymorphisms Within CD2AP in Patients With Focal Segmental Glomerulosclerosis Gopa B. Green, Jeong Kim, Cheryl Winkler, Jeffrey Kopp, and Andrey Shaw Washington University School of Medicine, Department of Internal Medicine, Renal Division, St Louis, MO; Washington University School of Medicine, Department of Pathology, St Louis, MO; and National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD
87
IgA Nephropathy: Linkage to a New Locus on Chromosome 12 Abhay Vats, Saju Joy, Michael Barmada, Michael Moritz, Demetrius Ellis, Ron Jaffe, and Robert Ferrell Department of Pediatrics, and Pathology, Childrens Hospital of Pittsburgh, Pittsburgh, PA; and Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA
27
A Novel Polymorphism in CD2AP May Decrease Binding Affinity for Nephrin in a Patient With Diffuse Mesangial Sclerosis Gopa B. Green, Jeong Kim, Ania Koziell, and Andrey S. Shaw Washington University School of Medicine, Department of Internal Medicine, Renal Division, St Louis, MO; Washington University School of Medicine, Department of Pathology, St Louis, MO; and Institute of Child Health, University College, London, UK
69
Ovarian Cancer Associated With Focal Segmental Glomerulosclerosis Sai Subhodhini Reddy University of Rochester Medical Center, Rochester, NY
70
Sarcoidosis Presenting With Severe Hypercalemia Sai Subhodhini Reddy University of Rochester Medical Center, Rochester, NY
71
T Cells From an MRL Autoimmune Mouse Are Preferentially Activated by B Cells Pulsed With Chromatin-Containing Immune Complexes and Recognize an Immunoglobulin Light Chain Transgene-Associated Product Ian R. Rifkin, Melissa Boule´, Elizabeth A. Leadbetter, and Ann Marshak-Rothstein Boston University School of Medicine, Departments of Medicine and Microbiology, Boston, MA
10
Thick Basement Membrane Syndrome Pramod Bhargava and Patrick Walker UAMS, Little Rock, AR
A4
ELEVENTH ANNUAL CLINICAL NEPHROLOGY MEETING ABSTRACTS
Hemodialysis 53
10% Electrolytic Chloroxidizing Agent (ExSept Plus) to Reduce Infection Rates in Dialysis Patients G.J. Mishkin, J. Ogilvie, and M. Mishkin Alcavis International, Inc, Gaithersburg, MD; and George Washington University, Washington, DC
56
Adequacy and Survival of Native Arteriovenous Fistula in African American Hemodialysis Patients Chamberlain I. Obialo, Albert T. Tagoe, Phyllis C. Martin, and Pearl E. Asche-Crowe Morehouse School of Medicine, Atlanta, GA
90
AranespTM (Darbepoetin Alfa) Administered at a Reduced Frequency of Once Every 4 Weeks (Q4W) Maintains Hemoglobin Levels in Patients With Chronic Kidney Disease (CKD) Receiving Dialysis Rowan Walker on behalf of the European/Australian 20000144 Study Team Royal Melbourne Hospital, Melbourne, Australia
18
A Comparison of Cath Flo and Retavase in the Declotting and Subsequent Dialysis of Central Venous Dialysis Catheters Roderick V. Clark and Judy A. Boe Acadiana Renal Physicians and Our Lady of Lourdes RMC, Lafayette, LA
84
Effect of Phosphorus Levels on Treatment of Vitamin D and an Analog in PTH Suppression in Endstage Renal Disease Stefan Tachev, Jonathan Weitzman, Karthik Ranganna, Shirin Khatoon, Jean Lee, and Ziauddin Ahmed Medical College of Pennsylvania Hospitals, Philadelphia, PA
13
Effectiveness of Mupirocin in Preventing Tunneled Catheter Related Bacteremia in Hemodialysis (HD) Patients Renee Burr, Beth Piraino, Michelle Shields, Vicky Gouker, and Nabeel Aslam University of Pittsburgh School of Medicine and DCI of Oakland, Pittsburgh, PA
9
Evaluation of Bone Disease and Coronary Calcifications in Patients With End-Stage Renal Disease Lada Beara-Lasic, Maria V. DeVita, and Michael F. Michelis Nephrology Section, Department of Medicine, Lenox Hill Hospital, New York, NY
52
Gender Differences in Outcomes of Arteriovenous (A-V) Fistula in Hemodialysis Patients Christopher D. Miller, Michelle L. Robbin, and Michael Allon Division of Nephrology and Division of Ultrasound, Department of Radiology, University of Alabama at Birmingham, Birmingham, AL
59
Hyperphosphatemia in Dialysis Patients—Is There a Role for Focused Counseling? Rajiv D. Poduval, Chris Wolgemuth, Janice Ferrell, and Mary S. Hammes University of Chicago, Chicago, IL
35
Impact of Malnutrition Inflammation Complex Syndrome on EPO Hyporesponsiveness Kamyar Kalantar-Zadeh, Robert S. Lehn, and Joel D. Kopple Harbor-UCLA Medical Center, Torrance, CA; and DaVita Laboratories, DeLand, FL
76
Improved Anemia Management in Haemodialysis Patients With Change in Intra-Dialysis Anti-Coagulation Protocol Peter Rutherford and Toni Jarvis University of Wales College of Medicine, Wrexham, UK
ELEVENTH ANNUAL CLINICAL NEPHROLOGY MEETING ABSTRACTS
A5
50
In Vitro Studies for Prevention of Hemodialysis Vascular Access Stenosis: Genetic Approach Takahisa Masaki and Alfred K. Cheung University of Utah, Department of Medicine & VA Salt Lake City Health Care System, Salt Lake City, UT
97
Increased Incidence of Hemodialysis Catheter Infections With Intravenous Iron Administration Maria Criselda Zaldivar, Smith A. Mellacheruvu, Andre A. Kaplan, and Nancy D. Adams University of Connecticut Health Center, Farmington, CT
3
Increasing Native AVF Usage—A Successful Multidisciplinary Effort Alexandre Ackad, Gregory Simonian, Michael Shapiro, Charles Moss, Massimo Napolitano, Christopher Parisi, Daryl Buckner, Sharon Mancini, Judith Haystrand, and Claudia Douglas Hackensack University Medical Center, Renal Division, Hackensack, NJ
41
Influence of a Fistula vs. Graft on C-Reactive Protein Levels Over Time Mitchell Kirsch, E. Ilamathi, B. Moore, M. Finger, N. Caraiani, and Irene Yarusso Suffolk Nephrology Consultants, P.C., Stonybrook, NY
36
Is Serum Homocysteine a Nutritional Marker in Maintenance Hemodialysis Patients? Kamyar Kalantar-Zadeh and Joel D. Kopple UCLA School of Medicine, Harbor-UCLA Medical Center Nephrology, Torrance, CA
33
Is Spironolactone Safe for Dialysis Patients? Shahid Hussain, Darren E. Dreyfus, Rita L. McGill, Robert W. Biederman, and Richard J. Marcus Division of Nephrology and Hypertension, Division of Cardiology, West Penn Allegheny Health System, Allegheny General Hospital, Pittsburgh, PA
94
Left Ventricular Hypertrophy Was Associated With Endothelium-Independent Dilatation of Vascular Smooth Muscle A. Yildiz, H. Oflaz, H. Pusuroglu, H. Genchallac, V. Akkaya, O. Ozsaruhan, E. Ark, A. Ikizler, and F. Erzengin Istanbul School of Medicine, Department of Internal Medicine, Division of Nephrology, Cardiology, Radiology, Istanbul, Turkey; and VUMC, Division of Nephrology, Nashville, TN
81
Markers of Apoptosis and Cellular Death in Patients on Chronic Hemodialysis Lygeri P. Soubassi, Angeliki Sarandakou, Basilis Kotsis, Dimitrios I. Chaniotis, Stylianos N. Zerefos, Sofia P. Soubassi, and Nicholas S. Zerefos Department of Clinical Therapeutics, University of Athens, Athens, Greece; and Hormone Laboratory, Aretaieion University of Athens, Athens, Greece
74
Parathyroid Hormone: Another Nutritional Marker in Dialysis Patients Rajeev Rohatgi, William Heneghan, and Jaime Uribarri Renal Division, Mount Sinai School of Medicine, New York, NY; and The Brooklyn Hospital, Brooklyn, NY
29
Prospective, Randomized Double-Blind Study of the Safety, Efficacy and Therapeutic Dose of Alteplase (t-PA) in the Treatment of Occluded Hemodialysis Catheters Mary S. Hammes, Janice Ferrell, and Rajiv D. Poduval University of Chicago, Chicago, IL
8
Retrospective Analysis of the Effects of IV Levocarnitine Six Months Before, During And Following Therapy J. Bazemore and S. Woolen Savannah Dialysis Unit, Savannah, GA
A6
ELEVENTH ANNUAL CLINICAL NEPHROLOGY MEETING ABSTRACTS
20
Risk Factors for Dialysis PTFE Graft Loss Chris Enoch, Linda Fried, and Paul Palevsky VA Pittsburgh Healthcare System, Pittsburgh, PA
82
Serum Leptin Levels in Chronic Hemodialysis Patients Dialysed With Different Types of Membranes Lygeri P. Soubassi, Dimitrios I. Chaniotis, Angeliki Sarandakou, Sofia P. Soubassi, Stylianos N. Zerefos, and Nicholas S. Zerefos Department of Clinical Therapeutics, University of Athens, Athens, Greece; and Hormone Laboratory, Aretaieion University of Athens, Athens, Greece
15
Vascular Access (VA) Management in Pediatric Hemodialysis Patients Vimal Chadha, Cindy George, Linda Jones, Walter S. Andrews, and Bradley A. Warady Children’s Mercy Hospital, Kansas City, MO
Hypertension 91
Benefits of BP Control Using ACE/CCB in Type 2 Diabetics Matthew R. Weir and George Bakris University of Maryland School of Medicine, Baltimore, MD; and Rush Presbyterian/St. Luke’s Medical Center, Chicago, IL
88
Blunted Nighttime Blood Pressure in Elderly Hypertensives Sridhar R.Vennamaneni and Vinod Miryala
89
Differential Control of Systolic and Diastolic Blood Pressure in Patients Referred to the Hypertension Clinic Sridhar R.Vennamaneni and Vinod Miryala
64
Gitelman’s Syndrome (GS) and Hypertension (HTN) in Two African American Siblings, a Paradox in HTN Nash N. Purohit, Leo Ovadje, Ramon Lopez, and Jacques A. Durr University of South Florida, College of Medicine, Tampa, FL
30
Maternal and Perinatal Outcomes in Pregnant Women With Borderline Hypertension and Reduced Renal Reserve R. Heguile´n, A. Lapidus, C. Paz, O. Mulki, D. Belluschi, L. Voto, and A. Bernasconi Departments of Nephrology, Obstetrics and Laboratory, Hospital Juan A Fernandez, Buenos Aires, Argentina
Peritoneal Dialysis 77
Peritonitis and Automated Peritoneal Dialysis (APD)—Difficulties in Management Peter Rutherford, Ines Held, and Liz Copper University of Wales College of Medicine, Wrexham, UK
Progressive Renal Failure 75
Aggressive Anemia Management in Pre-Dialysis Patients Using Erythropoietin and Intravenous Iron Peter Rutherford and Toni Jarvis University of Wales College of Medicine, Wrexham, UK
40
Clinical Characteristics of Chronic Kidney Disease (CKD) and Associated Disease Progression Douglas Keith, Dave Smith, Greg Nichols, Johnathan Brown, and Seonyoung Ryu Kaiser Permanente Center for Health Research, Portland, OR; and Amgen Inc, Thousand Oaks, CA
ELEVENTH ANNUAL CLINICAL NEPHROLOGY MEETING ABSTRACTS
45
Contribution of Endothelin-1 (ET-1)/Endothelin B (ETB) Receptor Pathway to Hypokalemic Nephropathy C. Licht, J.X. Zhou, K. Laghmani, M. Yanagisawa, R.J. Alpern, and P.A. Preisig UT Southwestern and HHMI, Dallas, TX
47
Differences in Urinary Osteopontin Between Male and Female Calcium Oxalate Stone Formers G. Maidoh, J. Lindberg, L. Hamm, F. Husserl, D. Kok, F. Cole, and A.V. Jack Section of Nephrology, Ochsner Medical Foundation, New Orleans, LA; Section of Nephrology, Tulane University School of Medicine, New Orleans, LA; Section of Nephrology, Louisiana State School of Medicine, New Orleans, LA; Research Division, Ochsner Medical Foundation, New Orleans, LA; and Erasmus Medical Centre, Rotterdam, The Netherlands
43
Discordance Between Urinary Citrate Excretion and Agglomeration Inhibition in Calcium Oxalate Stone Formers After Potassium Citrate Therapy C. Kyle, J. Lindberg, L. Hamm, F. Husserl, H. Fuselier, D. Kok, A. Jack, and F. Cole Research Division, Ochsner Medical Foundation, New Orleans, LA; Louisiana State University School of Medicine, New Orleans, LA; Ochsner Medical Foundation, New Orleans, LA; Section of Nephrology, Tulane University School of Medicine, New Orleans, LA; Department of Urology, Ochsner Medical Foundation, New Orleans, LA; and Erasmus Medical Centre, Rotterdam, The Netherlands
34
Safety Profile of High Dose Ferric Gluconate in Patients With Severe Chronic Renal Insufficiency Anil Jain and Bahar Bastani Division of Nephrology, St Louis University School of Medicine, St Louis, MO
A7
Transplantation 28
Ad-CTLA4Ig But Not Ad-CD40Ig Prolongs Allogeneic Islet Graft Survival in a Murine Islet Transplantation Model Mounir A. Hajjar, Andrew M. Posselt, Jiena Lang, Gregory L. Szot, George J. Chang, and Peter G. Stock University of California, San Francisco, CA
48
Case Reports of Cerebral Mucormycosis in Kidney Transplant Patients on Tacrolimus Mary C. Mallappallil, Sabu John, Eli Friedman, and Mariana Markell State University of New York at Brooklyn, Downstate Medical Center, Department of Nephrology, Brooklyn, NY
1
95
2
Drug-Induced Tubululo-Interstitial Nephritis Mimicking Acute Cellular Rejection After Kidney Transplantation Walid Aboujaoude, Lisa Cabrera, Sherry Abboud, Charles Nolan III, Wajeh Qunibi, and Daniel Riley University of Texas Health Sciences Center, San Antonio, TX Effects of CD40/CD154 Blockade on Allograft Rejection X. Yuan, V.M. Dong, A.J. Coito, A. Waaga, A.D. Salama, C.D. Benjamin, M.H. Sayegh, and A. Chandraker Brigham and Women’s Hospital, Boston, MA Effects of Rapamycin and Cyclosporine a on Proliferation of Renal Arterial Smooth Muscle Cells Walid Aboujaoude, Denis Fe´liers, and Daniel Riley University of Texas Health Sciences Center, San Antonio, TX
A8
ELEVENTH ANNUAL CLINICAL NEPHROLOGY MEETING ABSTRACTS
38
Factors Associated With Increased Time to Wait-list for Cadaveric Kidney Transplant in Dialysis Patients Waqar Kazmi and Samina S. Khan New England Medical Center, Boston, MA
37
The Impact of B Cell Crossmatch Positivity on Kidney Allograft Outcomes: A Single Center Experience Mark Kasari, Peter Leopold, Lawrence Hunsicker, Elizabeth Field, and Roberto Kalil Department of Medicine, University of Iowa Hospitals and Clinics, Iowa City, IA
39
Late Referral and Its Association With Probability of Being Wait-Listed for Cadaveric Kidney Transplant Waqar Kazmi and Samina S. Khan New England Medical Center, Boston, MA
4
Post-Transplant Neoplasms: 34-Year Experience Mahendra Agraharkar, Robert Cinclair, Mark Fahlen and John Daller Nephrology Division and Abdominal Transplant Program, University of Texas Medical Branch, Galveston, TX
Other 46
AransepTM (Darbepoetin Alfa) Administered Once Every Other Week (Q2W) Corrects Anemia in Patients With Chronic Kidney Disease (CKD) Jill S. Lindberg, Jesus Navarro, Michael Suranyi, and Rowan Walker Alton Ochsner Medical Foundation, New Orleans, LA; Genesis Clinical Research Corporation, Tampa, FL; and Liverpool Hospital, Sydney, Australia, Royal Melbourne Hospital, Melbourne, Australia
85
Cardioprotective Medications and Outcomes in Chronic Dialysis Patients Fernando Trespalacios, Robert Jeschke, Allen Taylor, Lawrence Agodoa, and Kevin Abbott Walter Reed Army Medical Center, Department of Medicine, Washington, DC
44
Characteristics of Medically Competent Patients Who Chose to Withdraw From Dialysis Lisa Leinau, Margaret Grove, Anna Tosteson, Brenda Carpenter, Brian Remillard, and Martha Graber Dartmouth-Hitchcock Medical Center, Lebanon, NH
25
Comparison of Ankle Quantitative Ultrasound (QUS) and Dual-Energy X-Ray Absorptionmetry (DEXA) Scans in Patients With Chronic Kidney Disease and Prolonged Cortiosteroid Therapy Darren W. Grabe, Marcia Chan, and George Eisele Albany College of Pharmacy and Albany Medical College, Albany, NY
67
Correction of Hemoglobin and Outcomes in Renal Insufficiency (CHOIR): Study Design Donal Reddan, Ly-Le Tran, and Ajay Singh Division of Nephrology, Duke University, Durham, NC; Ortho Biotech Products, L.P., Raritan, NJ; and Brigham and Womens Hospital, Harvard Medical School, Boston, MA
65
Correlation of Carotid and Coronary Disease in Patients With Significant Renal Artery Stenosis (or in Patients Who Underwent Renal Artery Stent Placement) Abbas Rabiei, Ali Ghorbani, Asad Majid, Anish Shah, Sam Kantor, Karthik Rangana, Robert Konigsberg, Daniel McCormick, Jean Lee, and Ziauddin Ahmed Medical College of Pennsylvania and Hahnemann University, Philadelphia, PA
ELEVENTH ANNUAL CLINICAL NEPHROLOGY MEETING ABSTRACTS
A9
19
Depression Predicts Survival in PD Patients Rebecca Einwohner, Judith Bernardini, and Beth Piraino University of Pittsburgh, Renal Division, Pittsburgh, PA
78
The Determinants of QT Interval Prolongation in Chronic Renal Disease Wilner Samson, Jonathan Winston, and Jaime Uribarri Mount Sinai School of Medicine, New York, NY
62
Effects of Intradialytic Parenteral Nutrition (IDPN) on Protein Metabolism in Chronic Hemodialysis Patients (CHD) Lara Pupim, John Brouillette, Deanna Levenhagen, Raymond Hakim, Paul Flakoll, and T. Alp Ikizler Vanderbilt University, Nashville, TN
80
High Blood Pressure (BP) Increases Risk of Post-Biopsy Bleeding in Patients Undergoing Native Kidney Biopsy Ganesh Shidham, Nauman Siddiqi, Joseph Beres, and Walter Piering Medical College of Wisconsin, Milwaukee, WI
66
HRQOL Improvements in Anemic CKD Patients Treated With Darbepoetin Alfa (ARANESPTM) S.N. Rahman, K.J. Heifner, S.Z. Fadem, M.E. McIvor, R.M. Brenner, K.M. Powers, and J.M. Ford for the NESP 20000146 Study Group University of Texas Medical Center, Houston, TX; Renal Associates, Little Rock, AR; Houston Kidney Center, Houston, TX; St Petersburg Heart Center, St Petersburg, FL; and Amgen Inc, Thousand Oaks, CA
58
Identification of Protein Complexes Involving MAGI-1 in the Podocyte Kevin M. Patrie, Andrew J. Drescher, and Ben Margolis Department of Internal Medicine, University of Michigan, Ann Arbor, MI
98
Impact of a Chronic Renal Insufficiency (CRI) Management Program at Group Health Cooperative Ilan Zawadzki, Moshe Fridman, and Seonyoung Ryu Group Health Cooperative of Puget Sound; AMF Consulting Inc; and Amgen Inc
99
Integrin Signaling in Renal Tubulogenesis Roy Zent and Dong Chen Vanderbilt Medical Center, Nashville, TN
54
Loss of Bone Mineral Density (BMD) in Calcium Oxalate Kidney Stone Formers (CaOx SF) With Fractures (Fx) Thai Q. Nguyen, J.S. Lindberg, A.L. Burshell, C.O. Stehman-Breen, L.L. Hamm, F.E. Husserl, A. Jack, and F.E. Cole Nephrology Section, Ochsner Clinic Foundation, New Orleans, LA; Endocrinology Section, Ochsner Clinic Foundation, New Orleans, LA; Nephrology Division, University of Washington, Seattle, WA; and Nephrology Section, Tulane School of Medicine, New Orleans, LA.
49
Management of Anemia of Chronic Renal Insufficiency in Pre-End Stage Renal Disease Patients Kimdeep Mangat Los Angeles, CA
5
Neutron Activation Analysis: A Novel Method for Assaying Iohexol at Concentrations Necessary for Determining Glomerular Filtration Rate David A. Albert, Andrew J. Cohen, Christopher P. Reinhardt, and Eric W. Dickson Departments of Medicine, Physiology, Anesthesia, and Emergency Medicine, University of Massachusetts Medical School and BioPAL Inc, Worcester, MA
A10
ELEVENTH ANNUAL CLINICAL NEPHROLOGY MEETING ABSTRACTS
22
The Predictive Power of Prealbumin (PALB) in Peritoneal Dialysis (PD) May Be Different From That in Hemodialysis (HD) Patients (PTS) Paul A. Fein, Gopi Gundumalla, Arpitha Reddy, Neal Mittman, and Morrell M. Avram Avram Center for Kidney Diseases, The Long Island College Hospital, Brooklyn, NY
32
Prevalence of IL 1RA Polymorphism in the ESRD Population and Role in Cardiovascular Disease Adriana Hung, Omer Qureshy, David Lovett, and Kirsten L. Johansen UCSF and San Francisco VAMC, San Francisco, CA
60
Prevalence of Iron Deficiency in Progressive Renal Disease Patients at the Initiation of Dialysis James B. Post, Maria V. DeVita, Michael F. Michelis, and Barry M. Wilkes Nephrology Section, Department of Medicine, Lenox Hill Hospital, New York, NY
93
Randomized Trial of Folic Acid for Homocysteine Reduction in End-Stage Renal Disease Elizabeth Wrone, John Hornberger, James Zehnder, Linda McCann, Norman Coplon, and Stephen Fortmann Satellite Research and Stanford University, Palo Alto, CA
24
Residues Determining Cl Affinity Differences among Na-K-Cl Cotransport Splice Variants: New Insights Into Protein Topology Ignacio Gimenez and Biff Forbush Yale University, Department of Cellular and Molecular Physiology, New Haven, CT
16
Risk Factors for Early Renal Disease: Initial Results From the K.E.E.P.-Hawai’i Project Shiuh-Feng Cheng, Marjorie Mau, Margaret West, Kimberly Spencer, Richard Severino, Roland Ng, Jared Sugihara, and Richard Arakaki University of Hawaii, School of Medicine, Department of Medicine, Honolulu, HI
86
Scleroderma at End Stage Renal Disease in the United States: Patient Characteristics and Survival Fernando Trespalacios, Kevin Abbott, and Lawrence Agodoa Walter Reed Army Medical Center, Department of Medicine, Washington, DC
92
Urinary Inhibitors of Nephrolithiasis (NL) in Patients (PTS) With Chronic Renal Failure (CRF) and Calcium Oxalate Stone Formation (COSF) C. Westervelt, J. Lindberg, L. Hamm, F. Husserl, H. Fuselier, D. Kok, A. Jack, and F. Cole
17
Utilization of a New Urinalysis Strip for Proteinuria in Various Patient Populations L. Clark, M. Pugia, P. Anderson, L. Demers, and M. Tang Bayer Diagnostics, Elkhart, IN; Providence St Vincent Medical Center, Portland, OR; M.S. Hershey Medical Center, Hershey, PA; and Fletcher Allen Healthcare, Burlington, VT
100
Intravenous Paricalcitol Has Increased Side Effects Compared to Calcitriol R.B. Mazess and L. Elangovan Bone Care International, Middleton, WI; and Professional Practice Group, Darlington, WI
101
Efficacy of Reteplase for Restoration of Flow in Hemodialysis Access Catheters Abigail Falk, Wilner Samson, Victoria Teodorescu, Jaime Uribarri, and Joseph Vassalotti Mount Sinai Medical Center, Department of Radiology, Medicine, and Surgery, New York, NY
ELEVENTH ANNUAL CLINICAL NEPHROLOGY MEETING ABSTRACTS
1
3
2
4
A11
A12
ELEVENTH ANNUAL CLINICAL NEPHROLOGY MEETING ABSTRACTS
5
7
6
8
ELEVENTH ANNUAL CLINICAL NEPHROLOGY MEETING ABSTRACTS
9
11
10
12
A13
A14
ELEVENTH ANNUAL CLINICAL NEPHROLOGY MEETING ABSTRACTS
13
15
14
16
ELEVENTH ANNUAL CLINICAL NEPHROLOGY MEETING ABSTRACTS
17
19
18
20
A15
A16
ELEVENTH ANNUAL CLINICAL NEPHROLOGY MEETING ABSTRACTS
21
23
22
24
ELEVENTH ANNUAL CLINICAL NEPHROLOGY MEETING ABSTRACTS
25
27
26
28
A17
A18
ELEVENTH ANNUAL CLINICAL NEPHROLOGY MEETING ABSTRACTS
29
31
30
32
ELEVENTH ANNUAL CLINICAL NEPHROLOGY MEETING ABSTRACTS
33
35
34
36
A19
A20
ELEVENTH ANNUAL CLINICAL NEPHROLOGY MEETING ABSTRACTS
37
39
38
40
ELEVENTH ANNUAL CLINICAL NEPHROLOGY MEETING ABSTRACTS
41
43
42
44
A21
A22
ELEVENTH ANNUAL CLINICAL NEPHROLOGY MEETING ABSTRACTS
45
47
46
48
ELEVENTH ANNUAL CLINICAL NEPHROLOGY MEETING ABSTRACTS
49
51
50
52
A23
A24
ELEVENTH ANNUAL CLINICAL NEPHROLOGY MEETING ABSTRACTS
53
55
54
56
ELEVENTH ANNUAL CLINICAL NEPHROLOGY MEETING ABSTRACTS
57
59
58
60
A25
A26
ELEVENTH ANNUAL CLINICAL NEPHROLOGY MEETING ABSTRACTS
61
63
62
64
ELEVENTH ANNUAL CLINICAL NEPHROLOGY MEETING ABSTRACTS
65
67
66
68
A27
A28
ELEVENTH ANNUAL CLINICAL NEPHROLOGY MEETING ABSTRACTS
69
71
70
72
ELEVENTH ANNUAL CLINICAL NEPHROLOGY MEETING ABSTRACTS
73
75
74
76
A29
A30
ELEVENTH ANNUAL CLINICAL NEPHROLOGY MEETING ABSTRACTS
77
79
78
80
ELEVENTH ANNUAL CLINICAL NEPHROLOGY MEETING ABSTRACTS
81
83
82
84
A31
A32
ELEVENTH ANNUAL CLINICAL NEPHROLOGY MEETING ABSTRACTS
85
87
86
88
ELEVENTH ANNUAL CLINICAL NEPHROLOGY MEETING ABSTRACTS
89
91
90
92
A33
A34
ELEVENTH ANNUAL CLINICAL NEPHROLOGY MEETING ABSTRACTS
93
95
94
96
ELEVENTH ANNUAL CLINICAL NEPHROLOGY MEETING ABSTRACTS
97
99
98
100
A35
A36
101
ELEVENTH ANNUAL CLINICAL NEPHROLOGY MEETING ABSTRACTS
Acute Renal Failure Due to Ephedra-Containing Dietary Supplements Brenda May-DePaola, Ronnie Garcia, and Ronald Miller Internal Medicine Department, Naval Medical Center, Portsmouth, VA
14
A Randomized Controlled Trial of N-Acetylcysteine to Prevent Contrast Nephropathy Following Coronary Angiography Christopher Caputo, John H. Dokko, John H. Durham, Mohsen Pahlavan, Jan Keltz, Paula Dutka, Kevin Marzo, Tommy Zaharakis and Steven Fishbane Divisions of Nephrology and Hypertension and Cardiology, Winthrop University Hospital, Mineola, NY
21
A Retrospective Analysis of Oral Acetylcysteine Intervention to Prevent Radiographic Contrast-Induced Nephropathy in Patients Undergoing Coronary Angiography With Elevated Serum Creatinine Craig W. Erickson, Janet E. Erickson, Greg Wilsker, and Larissa Brunner Lehigh Valley Hospital, Department of Internal Medicine & Family Practice, Allentown, PA
6
A Retrospective Study of the Incidence of Acute Renal Failure (ARF) Associated With Milrinone Therapy Kamal Amin and Bahar Bastani Division of Nephrology, St Louis University School of Medicine, St Louis, MO
68
Continuous Renal Replacement Therapy in Critically Ill Patients: Patient Survival, Renal Function Recovery, and Associated Complications Sai Subhodhini Reddy, Arlene Sherman, and Rebeca Monk University of Rochester Medical Center, Rochester, NY
42
Extended Daily Dialysis (EDD) Controls Azotemia in Intensive Care Unit (ICU) Patients With Acute Renal Failure (ARF) Victoria A. Kumar, Robert Tseng, and Thomas A. Depner
23
Is Continuous Infusion Better Than Bolus Furosemide in Promoting Urine Flow Rate (UFR) in Acute Renal Failure? Ali Ghorbani, Asad Majid, Heena Contractor, Abbas Rabiei, Karthik Ranganna, Maria Smalley, Jean Lee, and Ziauddin Ahmed Medical College of Pennsylvania Hospital, Philadelphia, PA
79
Urea Volume of Distribution (Vurea) and Total Body Water (TBW) in Patients With Acute Renal Failure (ARF) M. Tugrul Sezer, Sree Hariachar, Nancy Gritter, Paul Flakoll, Deanne Levenhagen, Emil Paganini, Raymond M. Hakim, Jonathan Himmelfarb, and T. Alp Ikizler Vanderbilt University Medical Center, Nashville, TN; Cleveland Clinic Foundation, Cleveland, OH; and Maine Medical Center, Portland, ME
American Journal of Kidney Diseases, Vol 39, No 4 (April), 2002: pp A1-A35
A1
A2
ELEVENTH ANNUAL CLINICAL NEPHROLOGY MEETING ABSTRACTS
Diabetes 72
Albuminuria in the Type 2 Diabetic Baboon Hernan Rincon-Choles, Jeffrey L. Barnes, Xing L. Wang, Robert E. Shade, Joseph R. Haywood, Kenneth D. Carey, Anthony G. Comuzzie, and Hanna E. Abboud ALM VA Hospital, University of Texas Health Sciences Center, and SW Foundation for Biomedical Research, San Antonio, TX
61
Prevalence of Anemia in Diabetic Patients With Chronic Kidney Disease and Treatment With Epoetin Alfa Once Weekly Robert Provenzano, Daniel Lorber, and William McClellan Department of Nephrology, St John Hospital and Medical Center, Detroit, MI; Division of Endocrinology, New York Hospital Medical Center of Queens, Flushing, NY; and Department of Epidemiology, Emory University, Atlanta, GA
31
Transforming Growth Factor- (TGF-) System and Genetic Predisposition to Diabetic Nephropathy (DN) Chunmei Huang, Youngki Kim, M. Luiza A. Caramori, Alfred J. Fish, Stephen S. Rich, Michael E. Miller, Greg Russell, and Michael Mauer University of Minnesota, Minneapolis, MN; and Wake Forest School of Medicine, Winston-Salem, NC
Electrolyte and Acid Base Abnormalities 12
Acute Effect of CO2 on the Tyrosine Phosphorylation of Proteins in the Rabbit Renal Proximal Tubule Patrice Bouyer, Yuehan Zhou, Jose D. Rojas, and Walter F. Boron Yale University School of Medicine, Department of Cellular and Molecular Physiology, New Haven, CT
57
Albumin Accounts Entirely for the Anion Gap and, Via Na Speciation, Affects Calculated Osmolality L. Ovadje, M. McClendon, C. McFarren, V. Namrungroad, N. Purohit, R. Lopez, M. Blakenship, and J.A. Durr University of South Florida, College of Medicine, Tampa, FL
11 Characterization of V2 Vasopressin Receptor Distribution and Internalization in Polarized LLC-PK1 Cells Richard Bouley, Herbert Y. Lin, and Dennis A. Ausiello Massachusetts General Hospital, Renal Unit, Boston, MA 63
Cidofovir Induced Fanconi Syndrome and Nephrogenic Diabetes Insipidus Nash Purohit, Jacques Durr, and Ramon Lopez University of South Florida College of Medicine, Division of Nephrology, Tampa, FL; and Bay Pines VAMC, St Petersburg, FL
83
Constitutive Aquaporin 2 Recycling Occurs Via a Dynamin-Dependent and Clathrin-Mediated Endocytotic Pathway: S256 Phosphorylation Is Not a Requirement for the Constitutive Recycling Tian-Xiao Sun, Alfred Van Hoek, Yan Huang, Karen Blackburn, Margaret McLaughlin, and Dennis Brown Program in Membrane Biology, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA
73
Na Transport by Autosomal Recessive Polycystic Kidney Disease (ARPKD) Cystic Epithelia Rajeev Rohatgi, Patricia Wilson, and Lisa M. Satlin Divisions of Renal Medicine and Pediatric Nephrology, Mount Sinai School of Medicine, New York, NY
ELEVENTH ANNUAL CLINICAL NEPHROLOGY MEETING ABSTRACTS
7
A3
New Fluid Prescriptions for Dysnatremia Noha Barsoum and Barton Levine VAGLAHS and UCLA School of Medicine, Los Angeles, CA
Glomerular Diseases 96
Acute Renal Failure in Focal Segmental Glomerulosclerosis Resolved With Diuresis and Steroids Maria Criselda B. Zaldivar, Irfan S. Chughtai, Harold T. Yamase, and Andre A. Kaplan Nephrology Division, Department of Medicine and Department of Pathology, University of Connecticut Health Center, Farmington, CT
55
Successful Treatment of Unilateral Renal Vein Thrombosis Associated With Lupus Nephritis Using Systemic Thrombolysis Chike M. Nzerue Renal Section, Department of Medicine, Morehouse School of Medicine, Atlanta, GA
26
Genetic Polymorphisms Within CD2AP in Patients With Focal Segmental Glomerulosclerosis Gopa B. Green, Jeong Kim, Cheryl Winkler, Jeffrey Kopp, and Andrey Shaw Washington University School of Medicine, Department of Internal Medicine, Renal Division, St Louis, MO; Washington University School of Medicine, Department of Pathology, St Louis, MO; and National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD
87
IgA Nephropathy: Linkage to a New Locus on Chromosome 12 Abhay Vats, Saju Joy, Michael Barmada, Michael Moritz, Demetrius Ellis, Ron Jaffe, and Robert Ferrell Department of Pediatrics, and Pathology, Childrens Hospital of Pittsburgh, Pittsburgh, PA; and Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA
27
A Novel Polymorphism in CD2AP May Decrease Binding Affinity for Nephrin in a Patient With Diffuse Mesangial Sclerosis Gopa B. Green, Jeong Kim, Ania Koziell, and Andrey S. Shaw Washington University School of Medicine, Department of Internal Medicine, Renal Division, St Louis, MO; Washington University School of Medicine, Department of Pathology, St Louis, MO; and Institute of Child Health, University College, London, UK
69
Ovarian Cancer Associated With Focal Segmental Glomerulosclerosis Sai Subhodhini Reddy University of Rochester Medical Center, Rochester, NY
70
Sarcoidosis Presenting With Severe Hypercalemia Sai Subhodhini Reddy University of Rochester Medical Center, Rochester, NY
71
T Cells From an MRL Autoimmune Mouse Are Preferentially Activated by B Cells Pulsed With Chromatin-Containing Immune Complexes and Recognize an Immunoglobulin Light Chain Transgene-Associated Product Ian R. Rifkin, Melissa Boule´, Elizabeth A. Leadbetter, and Ann Marshak-Rothstein Boston University School of Medicine, Departments of Medicine and Microbiology, Boston, MA
10
Thick Basement Membrane Syndrome Pramod Bhargava and Patrick Walker UAMS, Little Rock, AR
A4
ELEVENTH ANNUAL CLINICAL NEPHROLOGY MEETING ABSTRACTS
Hemodialysis 53
10% Electrolytic Chloroxidizing Agent (ExSept Plus) to Reduce Infection Rates in Dialysis Patients G.J. Mishkin, J. Ogilvie, and M. Mishkin Alcavis International, Inc, Gaithersburg, MD; and George Washington University, Washington, DC
56
Adequacy and Survival of Native Arteriovenous Fistula in African American Hemodialysis Patients Chamberlain I. Obialo, Albert T. Tagoe, Phyllis C. Martin, and Pearl E. Asche-Crowe Morehouse School of Medicine, Atlanta, GA
90
AranespTM (Darbepoetin Alfa) Administered at a Reduced Frequency of Once Every 4 Weeks (Q4W) Maintains Hemoglobin Levels in Patients With Chronic Kidney Disease (CKD) Receiving Dialysis Rowan Walker on behalf of the European/Australian 20000144 Study Team Royal Melbourne Hospital, Melbourne, Australia
18
A Comparison of Cath Flo and Retavase in the Declotting and Subsequent Dialysis of Central Venous Dialysis Catheters Roderick V. Clark and Judy A. Boe Acadiana Renal Physicians and Our Lady of Lourdes RMC, Lafayette, LA
84
Effect of Phosphorus Levels on Treatment of Vitamin D and an Analog in PTH Suppression in Endstage Renal Disease Stefan Tachev, Jonathan Weitzman, Karthik Ranganna, Shirin Khatoon, Jean Lee, and Ziauddin Ahmed Medical College of Pennsylvania Hospitals, Philadelphia, PA
13
Effectiveness of Mupirocin in Preventing Tunneled Catheter Related Bacteremia in Hemodialysis (HD) Patients Renee Burr, Beth Piraino, Michelle Shields, Vicky Gouker, and Nabeel Aslam University of Pittsburgh School of Medicine and DCI of Oakland, Pittsburgh, PA
9
Evaluation of Bone Disease and Coronary Calcifications in Patients With End-Stage Renal Disease Lada Beara-Lasic, Maria V. DeVita, and Michael F. Michelis Nephrology Section, Department of Medicine, Lenox Hill Hospital, New York, NY
52
Gender Differences in Outcomes of Arteriovenous (A-V) Fistula in Hemodialysis Patients Christopher D. Miller, Michelle L. Robbin, and Michael Allon Division of Nephrology and Division of Ultrasound, Department of Radiology, University of Alabama at Birmingham, Birmingham, AL
59
Hyperphosphatemia in Dialysis Patients—Is There a Role for Focused Counseling? Rajiv D. Poduval, Chris Wolgemuth, Janice Ferrell, and Mary S. Hammes University of Chicago, Chicago, IL
35
Impact of Malnutrition Inflammation Complex Syndrome on EPO Hyporesponsiveness Kamyar Kalantar-Zadeh, Robert S. Lehn, and Joel D. Kopple Harbor-UCLA Medical Center, Torrance, CA; and DaVita Laboratories, DeLand, FL
76
Improved Anemia Management in Haemodialysis Patients With Change in Intra-Dialysis Anti-Coagulation Protocol Peter Rutherford and Toni Jarvis University of Wales College of Medicine, Wrexham, UK
ELEVENTH ANNUAL CLINICAL NEPHROLOGY MEETING ABSTRACTS
A5
50
In Vitro Studies for Prevention of Hemodialysis Vascular Access Stenosis: Genetic Approach Takahisa Masaki and Alfred K. Cheung University of Utah, Department of Medicine & VA Salt Lake City Health Care System, Salt Lake City, UT
97
Increased Incidence of Hemodialysis Catheter Infections With Intravenous Iron Administration Maria Criselda Zaldivar, Smith A. Mellacheruvu, Andre A. Kaplan, and Nancy D. Adams University of Connecticut Health Center, Farmington, CT
3
Increasing Native AVF Usage—A Successful Multidisciplinary Effort Alexandre Ackad, Gregory Simonian, Michael Shapiro, Charles Moss, Massimo Napolitano, Christopher Parisi, Daryl Buckner, Sharon Mancini, Judith Haystrand, and Claudia Douglas Hackensack University Medical Center, Renal Division, Hackensack, NJ
41
Influence of a Fistula vs. Graft on C-Reactive Protein Levels Over Time Mitchell Kirsch, E. Ilamathi, B. Moore, M. Finger, N. Caraiani, and Irene Yarusso Suffolk Nephrology Consultants, P.C., Stonybrook, NY
36
Is Serum Homocysteine a Nutritional Marker in Maintenance Hemodialysis Patients? Kamyar Kalantar-Zadeh and Joel D. Kopple UCLA School of Medicine, Harbor-UCLA Medical Center Nephrology, Torrance, CA
33
Is Spironolactone Safe for Dialysis Patients? Shahid Hussain, Darren E. Dreyfus, Rita L. McGill, Robert W. Biederman, and Richard J. Marcus Division of Nephrology and Hypertension, Division of Cardiology, West Penn Allegheny Health System, Allegheny General Hospital, Pittsburgh, PA
94
Left Ventricular Hypertrophy Was Associated With Endothelium-Independent Dilatation of Vascular Smooth Muscle A. Yildiz, H. Oflaz, H. Pusuroglu, H. Genchallac, V. Akkaya, O. Ozsaruhan, E. Ark, A. Ikizler, and F. Erzengin Istanbul School of Medicine, Department of Internal Medicine, Division of Nephrology, Cardiology, Radiology, Istanbul, Turkey; and VUMC, Division of Nephrology, Nashville, TN
81
Markers of Apoptosis and Cellular Death in Patients on Chronic Hemodialysis Lygeri P. Soubassi, Angeliki Sarandakou, Basilis Kotsis, Dimitrios I. Chaniotis, Stylianos N. Zerefos, Sofia P. Soubassi, and Nicholas S. Zerefos Department of Clinical Therapeutics, University of Athens, Athens, Greece; and Hormone Laboratory, Aretaieion University of Athens, Athens, Greece
74
Parathyroid Hormone: Another Nutritional Marker in Dialysis Patients Rajeev Rohatgi, William Heneghan, and Jaime Uribarri Renal Division, Mount Sinai School of Medicine, New York, NY; and The Brooklyn Hospital, Brooklyn, NY
29
Prospective, Randomized Double-Blind Study of the Safety, Efficacy and Therapeutic Dose of Alteplase (t-PA) in the Treatment of Occluded Hemodialysis Catheters Mary S. Hammes, Janice Ferrell, and Rajiv D. Poduval University of Chicago, Chicago, IL
8
Retrospective Analysis of the Effects of IV Levocarnitine Six Months Before, During And Following Therapy J. Bazemore and S. Woolen Savannah Dialysis Unit, Savannah, GA
A6
ELEVENTH ANNUAL CLINICAL NEPHROLOGY MEETING ABSTRACTS
20
Risk Factors for Dialysis PTFE Graft Loss Chris Enoch, Linda Fried, and Paul Palevsky VA Pittsburgh Healthcare System, Pittsburgh, PA
82
Serum Leptin Levels in Chronic Hemodialysis Patients Dialysed With Different Types of Membranes Lygeri P. Soubassi, Dimitrios I. Chaniotis, Angeliki Sarandakou, Sofia P. Soubassi, Stylianos N. Zerefos, and Nicholas S. Zerefos Department of Clinical Therapeutics, University of Athens, Athens, Greece; and Hormone Laboratory, Aretaieion University of Athens, Athens, Greece
15
Vascular Access (VA) Management in Pediatric Hemodialysis Patients Vimal Chadha, Cindy George, Linda Jones, Walter S. Andrews, and Bradley A. Warady Children’s Mercy Hospital, Kansas City, MO
Hypertension 91
Benefits of BP Control Using ACE/CCB in Type 2 Diabetics Matthew R. Weir and George Bakris University of Maryland School of Medicine, Baltimore, MD; and Rush Presbyterian/St. Luke’s Medical Center, Chicago, IL
88
Blunted Nighttime Blood Pressure in Elderly Hypertensives Sridhar R.Vennamaneni and Vinod Miryala
89
Differential Control of Systolic and Diastolic Blood Pressure in Patients Referred to the Hypertension Clinic Sridhar R.Vennamaneni and Vinod Miryala
64
Gitelman’s Syndrome (GS) and Hypertension (HTN) in Two African American Siblings, a Paradox in HTN Nash N. Purohit, Leo Ovadje, Ramon Lopez, and Jacques A. Durr University of South Florida, College of Medicine, Tampa, FL
30
Maternal and Perinatal Outcomes in Pregnant Women With Borderline Hypertension and Reduced Renal Reserve R. Heguile´n, A. Lapidus, C. Paz, O. Mulki, D. Belluschi, L. Voto, and A. Bernasconi Departments of Nephrology, Obstetrics and Laboratory, Hospital Juan A Fernandez, Buenos Aires, Argentina
Peritoneal Dialysis 77
Peritonitis and Automated Peritoneal Dialysis (APD)—Difficulties in Management Peter Rutherford, Ines Held, and Liz Copper University of Wales College of Medicine, Wrexham, UK
Progressive Renal Failure 75
Aggressive Anemia Management in Pre-Dialysis Patients Using Erythropoietin and Intravenous Iron Peter Rutherford and Toni Jarvis University of Wales College of Medicine, Wrexham, UK
40
Clinical Characteristics of Chronic Kidney Disease (CKD) and Associated Disease Progression Douglas Keith, Dave Smith, Greg Nichols, Johnathan Brown, and Seonyoung Ryu Kaiser Permanente Center for Health Research, Portland, OR; and Amgen Inc, Thousand Oaks, CA
ELEVENTH ANNUAL CLINICAL NEPHROLOGY MEETING ABSTRACTS
45
Contribution of Endothelin-1 (ET-1)/Endothelin B (ETB) Receptor Pathway to Hypokalemic Nephropathy C. Licht, J.X. Zhou, K. Laghmani, M. Yanagisawa, R.J. Alpern, and P.A. Preisig UT Southwestern and HHMI, Dallas, TX
47
Differences in Urinary Osteopontin Between Male and Female Calcium Oxalate Stone Formers G. Maidoh, J. Lindberg, L. Hamm, F. Husserl, D. Kok, F. Cole, and A.V. Jack Section of Nephrology, Ochsner Medical Foundation, New Orleans, LA; Section of Nephrology, Tulane University School of Medicine, New Orleans, LA; Section of Nephrology, Louisiana State School of Medicine, New Orleans, LA; Research Division, Ochsner Medical Foundation, New Orleans, LA; and Erasmus Medical Centre, Rotterdam, The Netherlands
43
Discordance Between Urinary Citrate Excretion and Agglomeration Inhibition in Calcium Oxalate Stone Formers After Potassium Citrate Therapy C. Kyle, J. Lindberg, L. Hamm, F. Husserl, H. Fuselier, D. Kok, A. Jack, and F. Cole Research Division, Ochsner Medical Foundation, New Orleans, LA; Louisiana State University School of Medicine, New Orleans, LA; Ochsner Medical Foundation, New Orleans, LA; Section of Nephrology, Tulane University School of Medicine, New Orleans, LA; Department of Urology, Ochsner Medical Foundation, New Orleans, LA; and Erasmus Medical Centre, Rotterdam, The Netherlands
34
Safety Profile of High Dose Ferric Gluconate in Patients With Severe Chronic Renal Insufficiency Anil Jain and Bahar Bastani Division of Nephrology, St Louis University School of Medicine, St Louis, MO
A7
Transplantation 28
Ad-CTLA4Ig But Not Ad-CD40Ig Prolongs Allogeneic Islet Graft Survival in a Murine Islet Transplantation Model Mounir A. Hajjar, Andrew M. Posselt, Jiena Lang, Gregory L. Szot, George J. Chang, and Peter G. Stock University of California, San Francisco, CA
48
Case Reports of Cerebral Mucormycosis in Kidney Transplant Patients on Tacrolimus Mary C. Mallappallil, Sabu John, Eli Friedman, and Mariana Markell State University of New York at Brooklyn, Downstate Medical Center, Department of Nephrology, Brooklyn, NY
1
95
2
Drug-Induced Tubululo-Interstitial Nephritis Mimicking Acute Cellular Rejection After Kidney Transplantation Walid Aboujaoude, Lisa Cabrera, Sherry Abboud, Charles Nolan III, Wajeh Qunibi, and Daniel Riley University of Texas Health Sciences Center, San Antonio, TX Effects of CD40/CD154 Blockade on Allograft Rejection X. Yuan, V.M. Dong, A.J. Coito, A. Waaga, A.D. Salama, C.D. Benjamin, M.H. Sayegh, and A. Chandraker Brigham and Women’s Hospital, Boston, MA Effects of Rapamycin and Cyclosporine a on Proliferation of Renal Arterial Smooth Muscle Cells Walid Aboujaoude, Denis Fe´liers, and Daniel Riley University of Texas Health Sciences Center, San Antonio, TX
A8
ELEVENTH ANNUAL CLINICAL NEPHROLOGY MEETING ABSTRACTS
38
Factors Associated With Increased Time to Wait-list for Cadaveric Kidney Transplant in Dialysis Patients Waqar Kazmi and Samina S. Khan New England Medical Center, Boston, MA
37
The Impact of B Cell Crossmatch Positivity on Kidney Allograft Outcomes: A Single Center Experience Mark Kasari, Peter Leopold, Lawrence Hunsicker, Elizabeth Field, and Roberto Kalil Department of Medicine, University of Iowa Hospitals and Clinics, Iowa City, IA
39
Late Referral and Its Association With Probability of Being Wait-Listed for Cadaveric Kidney Transplant Waqar Kazmi and Samina S. Khan New England Medical Center, Boston, MA
4
Post-Transplant Neoplasms: 34-Year Experience Mahendra Agraharkar, Robert Cinclair, Mark Fahlen and John Daller Nephrology Division and Abdominal Transplant Program, University of Texas Medical Branch, Galveston, TX
Other 46
AransepTM (Darbepoetin Alfa) Administered Once Every Other Week (Q2W) Corrects Anemia in Patients With Chronic Kidney Disease (CKD) Jill S. Lindberg, Jesus Navarro, Michael Suranyi, and Rowan Walker Alton Ochsner Medical Foundation, New Orleans, LA; Genesis Clinical Research Corporation, Tampa, FL; and Liverpool Hospital, Sydney, Australia, Royal Melbourne Hospital, Melbourne, Australia
85
Cardioprotective Medications and Outcomes in Chronic Dialysis Patients Fernando Trespalacios, Robert Jeschke, Allen Taylor, Lawrence Agodoa, and Kevin Abbott Walter Reed Army Medical Center, Department of Medicine, Washington, DC
44
Characteristics of Medically Competent Patients Who Chose to Withdraw From Dialysis Lisa Leinau, Margaret Grove, Anna Tosteson, Brenda Carpenter, Brian Remillard, and Martha Graber Dartmouth-Hitchcock Medical Center, Lebanon, NH
25
Comparison of Ankle Quantitative Ultrasound (QUS) and Dual-Energy X-Ray Absorptionmetry (DEXA) Scans in Patients With Chronic Kidney Disease and Prolonged Cortiosteroid Therapy Darren W. Grabe, Marcia Chan, and George Eisele Albany College of Pharmacy and Albany Medical College, Albany, NY
67
Correction of Hemoglobin and Outcomes in Renal Insufficiency (CHOIR): Study Design Donal Reddan, Ly-Le Tran, and Ajay Singh Division of Nephrology, Duke University, Durham, NC; Ortho Biotech Products, L.P., Raritan, NJ; and Brigham and Womens Hospital, Harvard Medical School, Boston, MA
65
Correlation of Carotid and Coronary Disease in Patients With Significant Renal Artery Stenosis (or in Patients Who Underwent Renal Artery Stent Placement) Abbas Rabiei, Ali Ghorbani, Asad Majid, Anish Shah, Sam Kantor, Karthik Rangana, Robert Konigsberg, Daniel McCormick, Jean Lee, and Ziauddin Ahmed Medical College of Pennsylvania and Hahnemann University, Philadelphia, PA
ELEVENTH ANNUAL CLINICAL NEPHROLOGY MEETING ABSTRACTS
A9
19
Depression Predicts Survival in PD Patients Rebecca Einwohner, Judith Bernardini, and Beth Piraino University of Pittsburgh, Renal Division, Pittsburgh, PA
78
The Determinants of QT Interval Prolongation in Chronic Renal Disease Wilner Samson, Jonathan Winston, and Jaime Uribarri Mount Sinai School of Medicine, New York, NY
62
Effects of Intradialytic Parenteral Nutrition (IDPN) on Protein Metabolism in Chronic Hemodialysis Patients (CHD) Lara Pupim, John Brouillette, Deanna Levenhagen, Raymond Hakim, Paul Flakoll, and T. Alp Ikizler Vanderbilt University, Nashville, TN
80
High Blood Pressure (BP) Increases Risk of Post-Biopsy Bleeding in Patients Undergoing Native Kidney Biopsy Ganesh Shidham, Nauman Siddiqi, Joseph Beres, and Walter Piering Medical College of Wisconsin, Milwaukee, WI
66
HRQOL Improvements in Anemic CKD Patients Treated With Darbepoetin Alfa (ARANESPTM) S.N. Rahman, K.J. Heifner, S.Z. Fadem, M.E. McIvor, R.M. Brenner, K.M. Powers, and J.M. Ford for the NESP 20000146 Study Group University of Texas Medical Center, Houston, TX; Renal Associates, Little Rock, AR; Houston Kidney Center, Houston, TX; St Petersburg Heart Center, St Petersburg, FL; and Amgen Inc, Thousand Oaks, CA
58
Identification of Protein Complexes Involving MAGI-1 in the Podocyte Kevin M. Patrie, Andrew J. Drescher, and Ben Margolis Department of Internal Medicine, University of Michigan, Ann Arbor, MI
98
Impact of a Chronic Renal Insufficiency (CRI) Management Program at Group Health Cooperative Ilan Zawadzki, Moshe Fridman, and Seonyoung Ryu Group Health Cooperative of Puget Sound; AMF Consulting Inc; and Amgen Inc
99
Integrin Signaling in Renal Tubulogenesis Roy Zent and Dong Chen Vanderbilt Medical Center, Nashville, TN
54
Loss of Bone Mineral Density (BMD) in Calcium Oxalate Kidney Stone Formers (CaOx SF) With Fractures (Fx) Thai Q. Nguyen, J.S. Lindberg, A.L. Burshell, C.O. Stehman-Breen, L.L. Hamm, F.E. Husserl, A. Jack, and F.E. Cole Nephrology Section, Ochsner Clinic Foundation, New Orleans, LA; Endocrinology Section, Ochsner Clinic Foundation, New Orleans, LA; Nephrology Division, University of Washington, Seattle, WA; and Nephrology Section, Tulane School of Medicine, New Orleans, LA.
49
Management of Anemia of Chronic Renal Insufficiency in Pre-End Stage Renal Disease Patients Kimdeep Mangat Los Angeles, CA
5
Neutron Activation Analysis: A Novel Method for Assaying Iohexol at Concentrations Necessary for Determining Glomerular Filtration Rate David A. Albert, Andrew J. Cohen, Christopher P. Reinhardt, and Eric W. Dickson Departments of Medicine, Physiology, Anesthesia, and Emergency Medicine, University of Massachusetts Medical School and BioPAL Inc, Worcester, MA
A10
ELEVENTH ANNUAL CLINICAL NEPHROLOGY MEETING ABSTRACTS
22
The Predictive Power of Prealbumin (PALB) in Peritoneal Dialysis (PD) May Be Different From That in Hemodialysis (HD) Patients (PTS) Paul A. Fein, Gopi Gundumalla, Arpitha Reddy, Neal Mittman, and Morrell M. Avram Avram Center for Kidney Diseases, The Long Island College Hospital, Brooklyn, NY
32
Prevalence of IL 1RA Polymorphism in the ESRD Population and Role in Cardiovascular Disease Adriana Hung, Omer Qureshy, David Lovett, and Kirsten L. Johansen UCSF and San Francisco VAMC, San Francisco, CA
60
Prevalence of Iron Deficiency in Progressive Renal Disease Patients at the Initiation of Dialysis James B. Post, Maria V. DeVita, Michael F. Michelis, and Barry M. Wilkes Nephrology Section, Department of Medicine, Lenox Hill Hospital, New York, NY
93
Randomized Trial of Folic Acid for Homocysteine Reduction in End-Stage Renal Disease Elizabeth Wrone, John Hornberger, James Zehnder, Linda McCann, Norman Coplon, and Stephen Fortmann Satellite Research and Stanford University, Palo Alto, CA
24
Residues Determining Cl Affinity Differences among Na-K-Cl Cotransport Splice Variants: New Insights Into Protein Topology Ignacio Gimenez and Biff Forbush Yale University, Department of Cellular and Molecular Physiology, New Haven, CT
16
Risk Factors for Early Renal Disease: Initial Results From the K.E.E.P.-Hawai’i Project Shiuh-Feng Cheng, Marjorie Mau, Margaret West, Kimberly Spencer, Richard Severino, Roland Ng, Jared Sugihara, and Richard Arakaki University of Hawaii, School of Medicine, Department of Medicine, Honolulu, HI
86
Scleroderma at End Stage Renal Disease in the United States: Patient Characteristics and Survival Fernando Trespalacios, Kevin Abbott, and Lawrence Agodoa Walter Reed Army Medical Center, Department of Medicine, Washington, DC
92
Urinary Inhibitors of Nephrolithiasis (NL) in Patients (PTS) With Chronic Renal Failure (CRF) and Calcium Oxalate Stone Formation (COSF) C. Westervelt, J. Lindberg, L. Hamm, F. Husserl, H. Fuselier, D. Kok, A. Jack, and F. Cole
17
Utilization of a New Urinalysis Strip for Proteinuria in Various Patient Populations L. Clark, M. Pugia, P. Anderson, L. Demers, and M. Tang Bayer Diagnostics, Elkhart, IN; Providence St Vincent Medical Center, Portland, OR; M.S. Hershey Medical Center, Hershey, PA; and Fletcher Allen Healthcare, Burlington, VT
100
Intravenous Paricalcitol Has Increased Side Effects Compared to Calcitriol R.B. Mazess and L. Elangovan Bone Care International, Middleton, WI; and Professional Practice Group, Darlington, WI
101
Efficacy of Reteplase for Restoration of Flow in Hemodialysis Access Catheters Abigail Falk, Wilner Samson, Victoria Teodorescu, Jaime Uribarri, and Joseph Vassalotti Mount Sinai Medical Center, Department of Radiology, Medicine, and Surgery, New York, NY
ELEVENTH ANNUAL CLINICAL NEPHROLOGY MEETING ABSTRACTS
1
3
2
4
A11
A12
ELEVENTH ANNUAL CLINICAL NEPHROLOGY MEETING ABSTRACTS
5
7
6
8
ELEVENTH ANNUAL CLINICAL NEPHROLOGY MEETING ABSTRACTS
9
11
10
12
A13
A14
ELEVENTH ANNUAL CLINICAL NEPHROLOGY MEETING ABSTRACTS
13
15
14
16
ELEVENTH ANNUAL CLINICAL NEPHROLOGY MEETING ABSTRACTS
17
19
18
20
A15
A16
ELEVENTH ANNUAL CLINICAL NEPHROLOGY MEETING ABSTRACTS
21
23
22
24
ELEVENTH ANNUAL CLINICAL NEPHROLOGY MEETING ABSTRACTS
25
27
26
28
A17
A18
ELEVENTH ANNUAL CLINICAL NEPHROLOGY MEETING ABSTRACTS
29
31
30
32
ELEVENTH ANNUAL CLINICAL NEPHROLOGY MEETING ABSTRACTS
33
35
34
36
A19
A20
ELEVENTH ANNUAL CLINICAL NEPHROLOGY MEETING ABSTRACTS
37
39
38
40
ELEVENTH ANNUAL CLINICAL NEPHROLOGY MEETING ABSTRACTS
41
43
42
44
A21
A22
ELEVENTH ANNUAL CLINICAL NEPHROLOGY MEETING ABSTRACTS
45
47
46
48
ELEVENTH ANNUAL CLINICAL NEPHROLOGY MEETING ABSTRACTS
49
51
50
52
A23
A24
ELEVENTH ANNUAL CLINICAL NEPHROLOGY MEETING ABSTRACTS
53
55
54
56
ELEVENTH ANNUAL CLINICAL NEPHROLOGY MEETING ABSTRACTS
57
59
58
60
A25
A26
ELEVENTH ANNUAL CLINICAL NEPHROLOGY MEETING ABSTRACTS
61
63
62
64
ELEVENTH ANNUAL CLINICAL NEPHROLOGY MEETING ABSTRACTS
65
67
66
68
A27
A28
ELEVENTH ANNUAL CLINICAL NEPHROLOGY MEETING ABSTRACTS
69
71
70
72
ELEVENTH ANNUAL CLINICAL NEPHROLOGY MEETING ABSTRACTS
73
75
74
76
A29
A30
ELEVENTH ANNUAL CLINICAL NEPHROLOGY MEETING ABSTRACTS
77
79
78
80
ELEVENTH ANNUAL CLINICAL NEPHROLOGY MEETING ABSTRACTS
81
83
82
84
A31
A32
ELEVENTH ANNUAL CLINICAL NEPHROLOGY MEETING ABSTRACTS
85
87
86
88
ELEVENTH ANNUAL CLINICAL NEPHROLOGY MEETING ABSTRACTS
89
91
90
92
A33
A34
ELEVENTH ANNUAL CLINICAL NEPHROLOGY MEETING ABSTRACTS
93
95
94
96
ELEVENTH ANNUAL CLINICAL NEPHROLOGY MEETING ABSTRACTS
97
99
98
100
A35
A36
101
ELEVENTH ANNUAL CLINICAL NEPHROLOGY MEETING ABSTRACTS